Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Transition to and Away From Injecting Drug Use Among Young Drug Users in Tehran, Iran: A Qualitative Study Publisher



Rahimimovaghar A1 ; Noroozi A1, 2 ; Page K3 ; Mohraz M4 ; Mcfarland W3 ; Malekafzali H5 ; Malekinejad M6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences (TUMS), Tehran, Iran
  2. 2. Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine (SATiM), Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Epidemiology and Biostatistics, Division of Preventive Medicine and Public Health and Global Health Sciences, University of California San Francisco, San Francisco, United States
  4. 4. Iranian Research Center for HIV/AIDS (IRCHA), Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Institute for Health Policy Studies, University of California San Francisco, 3333 California Street, Suite 265, San Francisco, 94118, CA, United States

Source: Iranian Journal of Psychiatry and Behavioral Sciences Published:2017


Abstract

Background: Iran has a large population of non-injection opioid users potentially at risk of initiation of drug injection. Objective:Weimplementedaqualitative study to characterize the factors facilitating transitionfromnon-injectiondruguse (NIDU) to injection drug use (IDU) and vice versa. Materials and Methods:We conducted 42 in-depth interviews among purposefully selected groups of injecting and non-injecting drug users and health workers, in 2011 in Tehran, Iran. The interviews were audio-recorded, transcribed and coded using OpenCode 3.6 software. Results: The predominant factor for transition from NIDU to IDU was a high level of drug dependence. IDU decreased the cost associated with drug use by several fold in the short-term. The influence of other injectors, either by learning directly from, encouraged by, feeling coerced by, or identifying with a lifestyle was also mentioned as a causal factor in the transition to IDU. Pleasure-seeking or desire to experience an immediate rush were rarely reported; rather, themes of the need to maintain functionality, reduce pain, and overcome financial difficulties emerged. Vein damage and other IDU-related physical health problems, as well as pressure from family were reasons for reverse transition (IDU to NIDU). Conclusions: New harm reduction approaches could focus on blocking the transition from NIDU to injection and promoting the return to less harmful routes of administration. © 2016, Mazandaran University of Medical Sciences.
Other Related Docs
15. Six-Year Follow-Up of People Who Use Methamphetamine in Iran: A Case Series Study, International Journal of High Risk Behaviors and Addiction (2023)
19. Pharmacological Therapies for Management of Opium Withdrawal, Cochrane Database of Systematic Reviews (2018)
37. Iran in Transition, The Lancet (2019)
38. Impact of Needle and Syringe Program Coverage on Hiv Incidence in People Who Inject Drugs, International Journal of High Risk Behaviors and Addiction (2017)